Yoshito Takahashi, MD, PhD

Articles by Yoshito Takahashi, MD, PhD

Endocrine Plus Uracil/Tegafur Therapy for Prostate Cancer

ByYoshinari Ono, MD, PhD,Ohinichi Ohshima, MD, PhD,Yoshito Takahashi, MD, PhD,Manabu Kuriyama, MD, PhD,Yukimichi Kawada, MD, PhD

July 1st 1999

A prospective, randomized clinical trial was conducted to evaluate the efficacy of endocrine chemotherapy with uracil and tegafur (in a molar ratio of 4:1 [UFT]) in patients with prostate cancer. The study included two

Latest Updated Articles

Endocrine Plus Uracil/Tegafur Therapy for Prostate Cancer
July 1st 1999

Trending on CancerNetwork

AI and MRD Take Center Stage on Day 2 of ASCO Breakthrough 2026

Cellular Therapy and Antibody-Drug Conjugates Shape Day 1 of ASCO Breakthrough 2026

Sigvotatug Vedotin Does Not Significantly Improve Survival in NSCLC Trial

41 Unexpected While Expecting: Rare Case of Pregnancy Associated Xanthogranulomatous Mastitis Masquerading as Malignancy

42 Intraoperative Frozen Analysis of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy Does Not Provide Additional Surgical Benefit and Increases the Rate of Unnecessary ALND in Clinically Node-Negative Breast Cancer Patients